Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $225.61M.
ENTERPRISE VALUE (EV)
$225.61M
Gossamer Bio, Inc.
Market Cap
$64.83M
Enterprise Value (EV)
$225.61M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Gossamer Bio, Inc. (GOSS) | $64.83M | $225.61M |
| XBiotech Inc. (XBIT)vs › | $65.85M | N/A |
| Alps Group Inc (ALPS)vs › | $63.56M | N/A |
| RenovoRx, Inc. (RNXT)vs › | $63.52M | $54.30M |
| InterCure Ltd. (INCR)vs › | $63.19M | $106.04M |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | $67.02M |
| iBio, Inc. (IBIO)vs › | $66.82M | $12.62M |
| Cingulate Inc. (CING)vs › | $67.01M | $44.90M |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.56M | $190.19M |
| Champions Oncology, Inc. (CSBR)vs › | $68.08M | $74.69M |
Market Cap
$64.83M
Total Debt
$198.51M
Cash
$37.73M
Enterprise Value
$225.61M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
